Betamethasone Dipropionate Ointment USP — Class III drug recall D-1391-2019
Terminated recall by Teligent Pharma, Inc., reported 2019-06-26, distributed nationwide. Failed Impurities/Degradation Specifications
| Recall number | D-1391-2019 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teligent Pharma, Inc., Buena, NJ, United States |
| Recall initiated | 2019-05-20 |
| Classified | 2019-06-14 |
| Reported by FDA | 2019-06-26 |
| Terminated | 2025-01-27 |
| Distributed | Nationwide (US) |
| Quantity | 9,360 tubes |
| Reason classes | specification failure |
| NDC | 52565-0019-15, 52565-0019-51 |
| Lot numbers | 11852 |
| Expiration dates | 2020-08 |
Product
Betamethasone Dipropionate Ointment USP, 0.05%* (Augmented), a) 15 gram (NDC 52565-019-15) and b) 50 gram (NDC 52565-019-51) tubed, Rx Only, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 06310
Reason for recall
Failed Impurities/Degradation Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1391-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.